- Home
- FTK vs LYEL Comparison
FTK vs LYEL Comparison
Compare FTK & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- LYEL
- Stock Information
- Founded
- FTK 1985
- LYEL 2018
- Country
- FTK United States
- LYEL United States
- Employees
- FTK N/A
- LYEL N/A
- Industry
- FTK Major Chemicals
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- FTK Industrials
- LYEL Health Care
- Exchange
- FTK Nasdaq
- LYEL Nasdaq
- Market Cap
- FTK 212.1M
- LYEL 207.7M
- IPO Year
- FTK N/A
- LYEL 2021
- Fundamental
- Price
- FTK $15.64
- LYEL $0.42
- Analyst Decision
- FTK Strong Buy
- LYEL Sell
- Analyst Count
- FTK 1
- LYEL 2
- Target Price
- FTK $8.00
- LYEL $1.00
- AVG Volume (30 Days)
- FTK 457.5K
- LYEL 645.5K
- Earning Date
- FTK 05-06-2025
- LYEL 05-13-2025
- Dividend Yield
- FTK N/A
- LYEL N/A
- EPS Growth
- FTK 683.07
- LYEL N/A
- EPS
- FTK 0.46
- LYEL N/A
- Revenue
- FTK $202,013,000.00
- LYEL $65,000.00
- Revenue This Year
- FTK $9.41
- LYEL N/A
- Revenue Next Year
- FTK $9.25
- LYEL N/A
- P/E Ratio
- FTK $33.91
- LYEL N/A
- Revenue Growth
- FTK 11.96
- LYEL N/A
- 52 Week Low
- FTK $3.30
- LYEL $0.39
- 52 Week High
- FTK $11.42
- LYEL $2.88
- Technical
- Relative Strength Index (RSI)
- FTK 88.83
- LYEL 43.75
- Support Level
- FTK $7.01
- LYEL $0.39
- Resistance Level
- FTK $15.72
- LYEL $0.45
- Average True Range (ATR)
- FTK 1.07
- LYEL 0.04
- MACD
- FTK 0.87
- LYEL 0.00
- Stochastic Oscillator
- FTK 96.76
- LYEL 20.83
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.